The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance

被引:7
|
作者
Baertschi, Steven W. [1 ]
Maxwell-Backer, Lindsay [1 ]
Clemens, Matthew [1 ]
Smitka, Tim A. [1 ]
Draper, Jerry R. [1 ]
Taylor, K. Wayne [1 ]
Kaerner, Andreas [1 ]
Jansen, Patrick J. [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
stability; degradation; forced degradation; stress testing; structure elucidation; prasugrel; effient; degradation products; impurities; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PREDICTION; IMPURITIES; BEHAVIOR; HPLC; IDENTIFICATION; AUTOXIDATION; OXIDATION;
D O I
10.1016/j.xphs.2019.04.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Prasugrel hydrochloride is the active ingredient in Effient (TM), a thienopyridine platelet inhibitor. An extensive study of the degradation chemistry of prasugrel hydrochloride (LY640315 hydrochloride) has been carried out on the drug substance (part I) and on the drug product (part II, future article) using a multidimensional approach including hydrolytic, oxidative, and photolytic stressing, computational chemistry, HPLC analysis, and structure elucidation by various spectroscopic techniques. The major degradation products formed from the drug substance under the various stress conditions have been isolated and structures unambiguously determined, and the pathways leading to these products have been proposed. Fourteen new (not previously disclosed) products were discovered and characterized, in addition to 4 degradation products that had been previously identified in the literature. The pathways indicate that prasugrel is susceptible to hydrolysis, autoxidation (both radical-initiated and single-electron mediated), and peroxide-mediated oxidation; in solution, prasugrel is susceptible to photodegradation. (c) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2842 / 2857
页数:16
相关论文
共 50 条
  • [1] Maintaining exercise capacity and quality of life in chronic heart failure Part 1-Drug treatment
    von Haehling, Stephan
    Arzt, Michael
    Doehner, Wolfram
    Edelmann, Frank
    Evertz, Ruben
    Ebner, Nicole
    Herrmann-Lingen, Christoph
    Garfias-Veitl, Tania
    Koziolek, Michael
    Noutsias, Michel
    Schulze, P. Christian
    Wachter, Rolf
    Hasenfuss, Gerd
    Laufs, Ulrich
    KARDIOLOGE, 2022, 16 (02): : 185 - 196
  • [2] Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance
    Ramulu, K.
    Kumar, T. Thilak
    Krishna, S. Radha
    Vasudev, R.
    Kaviraj, M.
    Rao, B. M.
    Rao, N. Someswara
    PHARMAZIE, 2010, 65 (03): : 162 - 168
  • [3] Important questions in Allergy: 1-drug allergy/hypersensitivity
    Demoly, P.
    Pichler, W.
    Pirmohamed, M.
    Romano, A.
    ALLERGY, 2008, 63 (05) : 616 - 619
  • [4] Gender in the Substance of Chemistry, Part 1: The Ideal Gas
    Kovacs, Agnes
    HYLE, 2012, 18 (02): : 95 - 120
  • [5] CME Certified Training Preservation of Performance and Quality of Life in chronic Heart Failure Part 1-Drug Therapy
    von Haehling, Stephan
    Arzt, Michael
    Doehner, Wolfram
    Edelmann, Frank
    Evertz, Ruben
    Ebner, Nicole
    Herrmann-Lingen, Christoph
    Garfias-Veitl, Tania
    Koziolek, Michael
    Noutsias, Michel
    Schulze, P. Christian
    Wachter, Rolf
    Hasenfuss, Gerd
    Laufs, Ulrich
    KARDIOLOGIE, 2022, 16 (02): : 185 - 196
  • [6] Important Information on Drug Safety: Use of Efient (Active substance: Prasugrel)
    不详
    JOURNAL FUR KARDIOLOGIE, 2009, 16 (3-4): : 130 - 130
  • [7] Drug eruption due to prasugrel hydrochloride: A case report and mini-review
    Kawasaki-Nagano, Midori
    Tamagawa-Mineoka, Risa
    Nakae, Makoto
    Wakabayashi, Yusuke
    Nakagawa, Hiroki
    Masuda, Koji
    Katoh, Norito
    JOURNAL OF DERMATOLOGY, 2019, 46 (09): : E325 - E326
  • [8] CPS 1-Drug discovery workbooks for high school and undergraduate students
    Madura, Jeffry D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [9] Common deficiencies in abbreviated new drug applications: part 1: Drug substance
    Srinivasan, Aloka
    Iser, Robert
    Pharmaceutical Technology, 2010, 34 (01) : 50 - 59
  • [10] PHYSICAL STUDIES OF DETOMIDINE HYDROCHLORIDE, A NEW DRUG SUBSTANCE
    LAINE, E
    TUOMINEN, V
    KAHELA, P
    LIPONKOSKI, L
    SJOHOLM, R
    ACTA PHARMACEUTICA SUECICA, 1983, 20 (06): : 451 - 460